UP Setting Up Medical Device Park in Greater Noida with INR 439 Cr Investment

The park will feature advanced equipment for cancer care, radiology, imaging, anaesthesia, cardiorespiratory support, pacemakers, and cochlear implants.

In a significant move towards realising Chief Minister Yogi Adityanath's vision of transforming Uttar Pradesh into a medical device manufacturing hub, the Yamuna Expressway Industrial Development Authority (YEIDA) is actively developing the Medical Device Park in Greater Noida.

The project spans 350 acres and is strategically located near Jewar Airport in Sector 28 of Greater Noida. The estimated investment for this project is INR 439 Cr, with a substantial portion of INR 190 Cr dedicated to the development of common infrastructure (CIF).

This Medical Device Park, which includes a Gamma Radiation facility for cancer care, aims to be a beacon of innovation in the medical device manufacturing sector.

Govt Incentives Supporting the Medical Device Park

As a comprehensive 'one-stop destination,' the Medical Device Park will host laboratories and centre facilities to streamline diverse medical tests in a centralised location. This strategic approach seeks to reduce manufacturing costs, optimise medical equipment utilisation, and foster a robust ecosystem for medical device manufacturing on a national scale.

To catalyse this initiative, the state government has introduced a scheme offering a one-time grant-in-aid for establishing common infrastructure facilities within the Medical Device Park.

The primary focus is on equipping the park with state-of-the-art equipment dedicated to cancer care, radiology, imaging, anaesthetics, cardiorespiratory support, pacemakers, and cochlear implants.

To establish Gamma Radiation facilities, YEIDA has initiated the Expression of Interest (EOI) process, inviting companies to participate. The operation, maintenance, and management of these facilities will be executed through the Public-Private Partnership (PPP) mode, with ongoing efforts to finalise work distribution.

Strategic Segmentation of Medical Device Park

The Medical Device Park is strategically organised into five key segments, addressing various facets of medical device manufacturing:

1. Cancer Care-Radiotherapy Medical Devices: Focuses on essential equipment like the rotation cobalt machine, radiotherapy simulation system, and Linac 4 brachytherapy system.

2. Radiology and Nuclear Imaging Systems: Aims to introduce crucial diagnostic tools such as MRI, CT scan, X-ray, SPECT scan, mammography, ultrasound machines, and cath labs.

3. Anaesthetics and Cardio-Respiratory Medical Devices: Facilitates the manufacturing of Anaesthesia workstations, Automated External Defibrillators (AEDs), Dialysis Machines, Dialyzers, and Peritoneal Dialyzer Kits.

4. Implantable Electronic Devices: Contributes to the production of cochlear implants, pacemakers, hip implants, knee implants, and insulin pump equipment.

5. In Vitro Diagnostics: Offers facilities such as biochemistry analysers, haematology analysers, immunoassays, coagulation analysers, and blood gas analysers.

The Medical Device Park's strategic approach, coupled with government support and incentives, positions Uttar Pradesh as a key player in the medical device manufacturing landscape.

The focus on cutting-edge technologies, including Gamma Radiation facilities for cancer care, showcases a commitment to advancing healthcare solutions and fostering innovation in the region.

As the project progresses, it is anticipated to create a conducive environment for research, development, and production in the medical device sector, contributing significantly to the overall growth of the healthcare industry in Uttar Pradesh.

In a similar development, the Gujarat government is preparing to inaugurate a medical device park in Nagalpar near Rajkot, covering an area of 250 acres, which is expected to be operational by the end of 2024. The Central government has granted financial aid of INR 250 Cr to support this initiative and fortify the state's healthcare infrastructure.

The medical device park is strategically crafted to be commercially viable and economically sustainable, aiming to attract significant investments. Projections suggest an anticipated influx ranging from $100 to $150 million over the next three years.